rs150837963
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004961.4(GABRE):c.1273G>A(p.Ala425Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000063 in 1,206,519 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111686Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33846
GnomAD3 exomes AF: 0.0000922 AC: 16AN: 173552Hom.: 0 AF XY: 0.0000507 AC XY: 3AN XY: 59134
GnomAD4 exome AF: 0.0000639 AC: 70AN: 1094833Hom.: 0 Cov.: 32 AF XY: 0.0000638 AC XY: 23AN XY: 360427
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111686Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33846
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1273G>A (p.A425T) alteration is located in exon 9 (coding exon 9) of the GABRE gene. This alteration results from a G to A substitution at nucleotide position 1273, causing the alanine (A) at amino acid position 425 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at